Atomium Culture

Atomium Culture

The Permanent Platform of Atomium Culture brings together some of the most authoritative universities, newspapers and businesses in Europe to increase the movement of knowledge: across borders, across sectors and to the public at large.
La plataforma permanente Atomium Culture reúne a las universidades, periódicos y empresas más prestigiosos de Europa para promover el flujo del conocimiento más allá de fronteras, entre sectores y hacia el público en general.

About us

Leading young European researchers have been selected by European research universities and the Scientific and Editorial Committees of AC to write an article about their work and the potential impact of this.

Chitosan — A Means to Combat Cancer?

Por: | 30 de septiembre de 2013

ME076 resized
By Jan Ignacak, Jagiellonian University in Krakow

Cancer treatment is among the major challenges of contemporary medicine. New studies raise hopes for an ultimate selection of a substance that — while inhibiting cancer cell metabolism — will not affect the metabolism of normal cells. Possibly, such compound might be chitosan — a product of chitin depolimerisation and deacetylation.

Seguir leyendo »

C077 resized
By Antonio José Ribeiro, University of Coimbra

Diabetes is one of the major causes of premature illness and death worldwide. For all people with type 1 diabetes and for some people with type 2 diabetes, insulin is essential to keep blood glucose levels under control. Insulin replacement therapy has been performed for decades by subcutaneous injections. The design of an alternative route for insulin delivery remains one of the most frustrating challenges in drug development. The oral route is potentially the most convenient delivery because it is non-invasive, decreases risk of contamination, and it is physiologically desirable, since the exogenous protein imitates the physiological pathway. However, it is limited by proteolytic degradation and the size of insulin, too large to transport across the intestinal mucosa.

Seguir leyendo »

Lipoic Acid: A Molecule with an Intriguing Past and a Promising Future

Por: | 23 de septiembre de 2013

ME073 image resized
By Anna Bilska, Jagiellonian University in Krakow

Lipoic acid, a compound discovered in the 1950s, is a molecule consisting of eight carbon atoms, two oxygen atoms and two sulfur atoms. During the decade that followed its discovery, researchers focused mostly on its structure and its role in metabolism; only a few of about 300 papers published at that time dealt with its therapeutic potential. The past two decades, however, have witnessed a surge of interest in the pharmacology of lipoic acid, particularly its therapeutic effects in the treatment of many apparently unrelated diseases, of which diabetes, atherosclerosis, neurodegenerative changes, joint diseases and AIDS are the ones studied most often. And the interest is already paying off.

Seguir leyendo »

C090 resized
By Daniel Wilson, Ludwig-Maximilians-Universität Munich

Current trends indicate that microbes have the upper hand in our ongoing struggle against bacterial infections. Firstly, there is an increasing prevalence of “superbugs” within the public health sector that have resistance to more than one drug; recent outbreaks of the enterohaemorrhagic E. coli (EHEC) were detected in Germany in
2011, and the New Delhi metallo-beta-lactamase-1 (NDM-1) strains appeared in the UK and Europe in 2010. Secondly, our arsenal for retaliation is limited by the lack of new classes of antibiotics entering into clinical practice — only three truly new classes of antibiotics have entered into clinical practice within the past 30 years. Moreover, the problem is compounded by the exodus of large pharmaceutical companies from the research and development of novel antimicrobial agents — an exodus at a time when our need is most dire. This leaves the burden of discovery of new antimicrobials as well as investigations into the mechanism of action of antibiotics predominantly in the hands of small biotech companies and academics, such as the research group headed by Dr. Daniel Wilson at the Gene Center of Ludwig-Maximilians-Universität (LMU), in München.

Seguir leyendo »

Eat Better to Combat Cancer

Por: | 16 de septiembre de 2013

ME070 resized
By Paula Ravasco, University of Lisbon

Researchers of the Unit of Nutrition and Metabolism — Institute of Molecular Medicine of the Faculty of Medicine of the University of Lisbon demonstrate for the first time the pivotal role that nutrition has on the Quality of Life, tolerance to treatments, improved prognosis, and longer survival of cancer patients.

Seguir leyendo »

Molecular Polymer Brushes as Smart Nanovalves

Por: | 12 de septiembre de 2013

C096 resized
By Szczepan Zapotoczny, Jagiellonian University in Krakow

Corporations and individual consumers focus on the tremendous benefits of making computers and cell phones ever smaller and more efficient. Less public attention has been paid to the advantages of ‘miniaturising’ sophisticated biomedical apparatuses and sensors. Full blood analysis from just a single drop; detection of traces of dangerous explosives or toxic substance in the environment; and non-invasive and controlled delivery of therapeutic substances are just a few examples of such benefits of miniaturisation.

Seguir leyendo »

Garlic Is Good for Your Health

Por: | 09 de septiembre de 2013

ME072 resized
By Malgorzata Iciek, Jagiellonian University in Krakow

Scientific and clinical research over the past 30 years has repeatedly shown garlic to be both preventive and therapeutic for cancer and cardiovascular diseases, the most common maladies of our times.

Garlic (Allium sativum L.), despite being used in medicine for thousands of years, continues to interest researchers and physicians given its wide spectrum of actions: garlic can not only kill bacteria, worms and fungi but also builds immunity and leaves the natural beneficial bacteria that live in our gut intact.

Seguir leyendo »

Therapeutic Properties of Nitric Oxide

Por: | 06 de septiembre de 2013

Atomium_Culture_Looking_Through_A_Microscope copy C091 resized
By Moisés Luzia Pinto, University of Lisbon

Cardiovascular problems are among the more important causes of death in many European countries. One therapeutic strategy for a person that has a cardiac disease or has had a brain stroke is the delivery of small amounts of nitric oxide (NO) to the affected area. This causes dilation of arteries and other blood vessels and prevents blood aggregation by aiding in the removal of blood clots or other restrictions from the affected area, thereby normalizing blood supply.

Seguir leyendo »

El País

EDICIONES EL PAIS, S.L. - Miguel Yuste 40 – 28037 – Madrid [España] | Aviso Legal